Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Kolb

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Protein & Cell|January 30, 2014
Inflammasomes in cancer: a double-edged swordRyan Kolb, Guang-Hui Liu, Ann M Janowski, et al.
The American Journal of Pathology|June 8, 2018
Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast CancerNicholas Borcherding, Kimberly Cole, Paige Kluz, et al.
Cancers|November 27, 2021
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell CarcinomaMyung-Chul Kim, Zeng Jin, Ryan Kolb, et al.
Cancers|September 23, 2022
Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. <i>Cancers</i> 2019, <i>11</i>, 718Gaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Cancers|May 30, 2019
ROR1 Potentiates FGFR Signaling in Basal-Like Breast CancerGaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Plos One|October 6, 2016
Involvement of the NLRC4-Inflammasome in Diabetic NephropathyFang Yuan, Ryan Kolb, Gaurav Pandey, et al.
Cells|August 27, 2025
Tissue-Resident Memory T Cells in Cancer Metastasis ControlTyler H Montgomery, Anuj P Master, Zeng Jin, et al.
Cancer Research|March 15, 2015
Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating CellsNicholas Borcherding, David Kusner, Ryan Kolb, et al.
Cancer Research Communications|August 6, 2024
ANGPTL4 Suppresses Clear Cell Renal Cell Carcinoma via Inhibition of Lysosomal Acid LipaseZeng Jin, Umasankar De, Tanzia Islam Tithi, et al.
Cancers|July 9, 2022
Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic ImplicationsLei Wang, Zeng Jin, Rohan P Master, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Protein & Cell|January 30, 2014
Inflammasomes in cancer: a double-edged swordRyan Kolb, Guang-Hui Liu, Ann M Janowski, et al.
The American Journal of Pathology|June 8, 2018
Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast CancerNicholas Borcherding, Kimberly Cole, Paige Kluz, et al.
Cancers|November 27, 2021
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell CarcinomaMyung-Chul Kim, Zeng Jin, Ryan Kolb, et al.
Cancers|September 23, 2022
Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. <i>Cancers</i> 2019, <i>11</i>, 718Gaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Cancers|May 30, 2019
ROR1 Potentiates FGFR Signaling in Basal-Like Breast CancerGaurav Pandey, Nicholas Borcherding, Ryan Kolb, et al.
Plos One|October 6, 2016
Involvement of the NLRC4-Inflammasome in Diabetic NephropathyFang Yuan, Ryan Kolb, Gaurav Pandey, et al.
Cells|August 27, 2025
Tissue-Resident Memory T Cells in Cancer Metastasis ControlTyler H Montgomery, Anuj P Master, Zeng Jin, et al.
Cancer Research|March 15, 2015
Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating CellsNicholas Borcherding, David Kusner, Ryan Kolb, et al.
Cancer Research Communications|August 6, 2024
ANGPTL4 Suppresses Clear Cell Renal Cell Carcinoma via Inhibition of Lysosomal Acid LipaseZeng Jin, Umasankar De, Tanzia Islam Tithi, et al.
Cancers|July 9, 2022
Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic ImplicationsLei Wang, Zeng Jin, Rohan P Master, et al.
Pageof 4